Pancreatic Cancer Research

ResearcherRuijin HospitalNo recent work listed

Haojun Shi

ORCID-verified (high confidence)As of 11 November 2026

Matched on ORCID iD 0000-0002-3361-6931; OpenAlex author ID A5102004197.

Their work

Papers
5 (first author 5, last author 0)
Trials
0
Grants
0
Collaborators
5
Papers, trials and grants by year

2016: 2 papers · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper

Papers 5

  1. Identification of ONECUT3 as a stemness-related transcription factor regulating NK cell-mediated immune evasion in pancreatic cancer. First author DOI 10.1038/s41598-023-45560-y↗
  2. Identification of CEACAM5 as a stemness-related inhibitory immune checkpoint in pancreatic cancer. First author DOI 10.1186/s12885-022-10397-7↗
  3. Complement component 1, q subcomponent binding protein (C1QBP) in lipid rafts mediates hepatic metastasis of pancreatic cancer by regulating IGF-1/IGF-1R signa… First author DOI 10.1002/ijc.30831↗
  4. Process of hepatic metastasis from pancreatic cancer: biology with clinical significance. First author DOI 10.1007/s00432-015-2024-0↗
  5. Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability. First author DOI 10.3748/wjg.v22.i45.10024↗

Closest collaborators

The 5 strongest of 5 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Yisi Yang · 2 shared papers, 2022–2023
  2. Deliang Fu · 3 shared papers, 2016–2017
  3. Hok Leong Chin · 1 shared paper, 2023
  4. Chen Jin · 1 shared paper, 2016
  5. Ji Li · 1 shared paper, 2016

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.